azaribine

11/01/1977 - "Pharmacological studies of neurotoxicity in patients with psoriasis treated with azaribine, utilizing high-pressure liquid chromatography."
02/01/1975 - "Double-blind controlled crossover high-dose study of Azaribine in psoriasis."
01/01/1975 - "An open study was made of 25 patients with severe, recalcitrant psoriasis treated with azaribine (6-azauridine triacetate). "
12/27/1977 - "Azaribine (triacetyl-6-azauridine) in psoriasis. "
12/01/1976 - "Azaribine is an effective agent in the treatment of psoriasis. "

01/01/1976 - "Azaribine appears to be a useful agent for trial in the treatment of refractory psoriatic arthritis."
01/01/1976 - "Treatment of psoriatic arthritis with azaribine."
01/01/1976 - "Thirty-two patients with psoriatic arthritis unresponsive to conventional therapy were treated wtih the antipyrimidine azaribine. "

02/01/1971 - "Azaribine for mycosis fungoides."
11/27/1970 - "[Typical hyperaminoaciduria in patients with mycosis fungoides and primary progressive polyarthritis following 6-azauridine triacetate administration]."
02/01/1966 - "Beneficial effects of triacetyl azauridine in psoriasis and mycosis fungoides."

01/01/1989 - "Azaribine-homocystinemia-thrombosis in historical perspective."
09/01/1977 - "Azaribine, homocystinemia, and thrombosis."

05/01/1970 - "Side effects of 6-azauridine triacetate in rheumatoid arthritis."
08/01/1995 - "This article describes pharmaceutical agents currently under investigation for use in rheumatoid arthritis, including the antiinflammatory agents, zileuton and tenidap, and the immunosuppressive agents, leflunomide, mycophenolic acid (RS-61443), tacrolimus (FK-506), sirolimus (rapamycin), amiprilose (therafectin), cladribine (2- chlorodeoxyadenosine), and azaribine."